Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Isomalto-oligosaccharide (IMO) is a prebiotic fiber that has garnered some scientific attention for its potential benefits in gut health, including applications for Inflammatory Bowel Disorders (IBD) such as Crohn's disease and ulcerative colitis. The primary rationale for its use is based on its ability to promote the growth of beneficial gut bacteria, particularly Bifidobacterium and Lactobacillus species, which are often depleted in individuals with IBD. These bacteria can ferment IMOs to produce short-chain fatty acids like butyrate, which may help reinforce the intestinal barrier and modulate immune responses.

However, the direct scientific evidence supporting IMO supplementation as a treatment or adjunct for IBD in humans is limited and preliminary. Most of the available research comes from in vitro studies or animal models, which suggest anti-inflammatory effects and improved gut barrier function. A few small human trials and clinical observations indicate that IMO may improve the composition of the gut microbiota and reduce some symptoms of gut discomfort, but robust, large-scale clinical trials specifically examining IMO in IBD patients are lacking. Current evidence does not justify its use as a primary therapy, but it may be considered a supportive measure for some patients interested in dietary interventions.

In summary, while there is a plausible scientific rationale and early supportive data, the evidence base is still insufficient for strong clinical recommendations. Thus, the evidence rating is 2/5.

More about isomalto-oligosaccharide
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by isomalto-oligosaccharide

Products containing isomalto-oligosaccharide

Nature's Sunshine Stixated
Nature's Sunshine Stomach Comfort (Chewable)